News | March 14, 2024
Zydus launches generic version of Olaparib ‘IBYRA’ in India
The drug will target specific genetic mutations prevalent in certain types of cancers
The drug will target specific genetic mutations prevalent in certain types of cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
It is the first autotaxin inhibitor to be investigated in cancer patients
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Women emerge as the cornerstone of this monumental undertaking
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The investment will catalyse various components of the IndiaAI Mission
Subscribe To Our Newsletter & Stay Updated
